Is Craniosynostosis-Dysmorphism-Brachydactyly Inherited?
At a Glance
Craniosynostosis-dysmorphism-brachydactyly syndrome can be either inherited from a parent or occur spontaneously as a completely new (de novo) mutation. To find out exactly how your child's condition occurred, doctors often use trio sequencing to compare the child's DNA with both parents.
In this answer
4 sections
When a child is diagnosed with a condition like craniosynostosis-dysmorphism-brachydactyly syndrome, parents often wonder whether the genetic change was passed down from them or if it happened completely by chance. While the condition is always caused by a change (mutation) in the child’s DNA, that mutation can either be inherited from one or both parents, or it can be a brand-new change that occurred spontaneously [1][2]. Understanding which scenario applies to your family requires specific genetic testing [3].
Conditions featuring craniosynostosis (early skull fusion), dysmorphism (distinct facial features), and brachydactyly (short fingers) can be caused by changes in several different genes, such as SLC25A24 or CDC45 [2][4]. These genes provide essential instructions for early bone, connective tissue, and energy metabolism development [5]. When they are altered, it changes how the skeleton forms, leading to premature skull fusion and shortened fingers [5]. Because the condition can be caused by different genes, the exact inheritance pattern depends on your child’s specific genetic results [2][4].
De Novo vs. Inherited Mutations
When doctors talk about how a genetic condition begins, they categorize the genetic change into one of two groups:
- De Novo (Spontaneous) Mutations: De novo means “anew” or “new.” These are genetic changes that happen completely by chance in the egg or sperm before conception, or very early in the embryo’s development [1][6]. If your child’s mutation is de novo, it means neither parent carries the genetic change in their blood, and nothing you did before or during pregnancy caused it [6]. Many rare craniosynostosis syndromes are the result of de novo mutations [4][5].
- Inherited Mutations: An inherited mutation is one that is passed down from one or both parents [2]. The parent might have mild symptoms of the condition themselves, or they might be a “silent carrier” who shows no signs at all [2].
How Inheritance Patterns Work
If the mutation is inherited, it generally follows one of two main patterns:
- Autosomal Dominant: In this pattern, only one copy of the changed gene is needed to cause the syndrome [4]. If a parent has the mutation, there is a 50% chance of passing it on to each child [4]. However, it is very common for autosomal dominant conditions to start as de novo mutations in the child, meaning the parents do not have the condition and their risk of having another child with it is very low [5].
- Autosomal Recessive: In this pattern, the child must inherit two copies of the changed gene—one from each parent—to have the condition [2]. The parents are typically healthy carriers who do not have the syndrome [2]. If both parents are carriers, there is a 25% chance with each pregnancy of having a child with the condition [2].
The Role of Trio Sequencing
To figure out exactly how your child’s mutation occurred, medical geneticists often use a highly effective test called trio whole-exome sequencing (trio-WES) [3][7].
“Trio” testing means that the laboratory takes DNA samples from the child and both biological parents at the same time [8]. By directly comparing the three sets of DNA, the lab can definitively see if the child’s mutation was inherited from a parent or if it is a de novo (new) change [1][9]. This testing is considered a crucial tool for diagnosing rare conditions involving structural malformations like craniosynostosis and brachydactyly [3].
Genetic Counseling and Family Planning
Learning that your child has a genetic syndrome often brings up heavy emotions, including unwarranted guilt [10]. A genetic counselor can help you navigate these feelings and clearly understand your trio sequencing results [10][11].
If the mutation is de novo, a genetic counselor can assure you that the recurrence risk for future pregnancies is typically very low [12]. It is usually around 1% due to a rare phenomenon called germline mosaicism, which is where a small number of a parent’s egg or sperm cells carry the mutation even though the rest of their body does not [12][1].
If the mutation is inherited, the counselor will explain your exact statistical risks and discuss family planning options [13]. These options might include prenatal testing during a future pregnancy or in vitro fertilization (IVF) with preimplantation genetic testing, which allows doctors to screen embryos for the specific mutation before pregnancy begins [13].
Common questions in this guide
Is craniosynostosis-dysmorphism-brachydactyly syndrome always passed down from parents?
What tests can show if my child's mutation was inherited?
What is the chance of having another child with this syndrome?
Which genes are responsible for this condition?
What are our options for future pregnancies if the mutation is inherited?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has the specific gene responsible for my child's syndrome (such as SLC25A24 or CDC45) been identified in our lab results yet?
- 2.Is trio whole-exome sequencing an option for our family, and what steps do we need to take to get tested?
- 3.If trio sequencing is recommended, is it typically covered by our insurance, and how long do the results usually take?
- 4.Based on our child's specific genetic results, what is the exact percentage risk of this condition occurring in future pregnancies?
- 5.What are our next steps if the genetic testing comes back inconclusive or finds nothing?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Optical genome mapping as a diagnostic tool for unsolved balanced translocations in couples with adverse pregnancy outcomes: a case series.
Zhang X, Liao Y, Cao L, et al.
European journal of medical research 2026; (31(1)):223 doi:10.1186/s40001-025-03814-7.
PMID: 41508122 - 2
Prenatal diagnosis of Meier-Gorlin syndrome 7: a case presentation.
Li X, Zhang LZ, Yu L, et al.
BMC pregnancy and childbirth 2021; (21(1)):381 doi:10.1186/s12884-021-03868-5.
PMID: 34000999 - 3
Application of trio-based whole-exome sequencing in fetal ultrasound anomalies: a single-center retrospective study of 454 cases.
Yu D, Feng D, Qu J, et al.
Frontiers in genetics 2025; (16()):1662801 doi:10.3389/fgene.2025.1662801.
PMID: 41367618 - 4
A 9-year-old Korean girl with Fontaine progeroid syndrome: a case report with further phenotypical delineation and description of clinical course during long-term follow-up.
Ryu J, Ko JM, Shin CH
BMC medical genetics 2019; (20(1)):188 doi:10.1186/s12881-019-0921-9.
PMID: 31775791 - 5
De Novo Mutations in SLC25A24 Cause a Craniosynostosis Syndrome with Hypertrichosis, Progeroid Appearance, and Mitochondrial Dysfunction.
Ehmke N, Graul-Neumann L, Smorag L, et al.
American journal of human genetics 2017; (101(5)):833-843 doi:10.1016/j.ajhg.2017.09.016.
PMID: 29100093 - 6
Parental Somatic Mosaicism Detected During Prenatal Diagnosis.
Chandler NJ, Scotchman E, McKay F, et al.
Prenatal diagnosis 2025; (45(2)):171-177 doi:10.1002/pd.6712.
PMID: 39586789 - 7
Diagnostic Yield of Exome Sequencing in Fetuses with Sonographic Features of Skeletal Dysplasias but Normal Karyotype or Chromosomal Microarray Analysis: A Systematic Review.
Tse KY, Surya IU, Irwinda R, et al.
Genes 2023; (14(6)) doi:10.3390/genes14061203.
PMID: 37372383 - 8
Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China.
Wang Y, Yin F, Chai Y, et al.
Frontiers in genetics 2023; (14()):1301439 doi:10.3389/fgene.2023.1301439.
PMID: 38318287 - 9
De Novo Mutation in KRT1 Leads to Epidermolytic Palmoplantar Keratoderma: from Chinese Traditional Treatment to Prenatal Diagnosis Using Whole-Exome Sequencing-Plus.
Ge M, Ji C, Li H, Huang H
DNA and cell biology 2023; (42(10)):645-652 doi:10.1089/dna.2023.0154.
PMID: 37566479 - 10
Comparative Diagnostic Assessment of Karyotyping, Microarray, and Whole Exome Sequencing in Genetically Associated Fetal Growth Restriction.
Luo L, Chen C, Cheung CKY, et al.
Diagnostics (Basel, Switzerland) 2026; (16(2)) doi:10.3390/diagnostics16020312.
PMID: 41594288 - 11
Prenatal diagnosis and genetic counseling of a Chinese family with inherited multiple chromosomal microduplications.
Hu F, Zhang G
Psychiatric genetics 2025; (35(3)):69-74 doi:10.1097/YPG.0000000000000391.
PMID: 40145879 - 12
Genetic testing for fetal loss of heterozygosity using single nucleotide polymorphism array and whole-exome sequencing.
Xue H, Yu A, Zhang L, et al.
Scientific reports 2024; (14(1)):2190 doi:10.1038/s41598-024-52812-y.
PMID: 38273042 - 13
Genetic analysis of 280 children with unexplained developmental delay or intellectual disability using whole exome sequencing.
Xu J, Su W, Wang Y, et al.
BMC pediatrics 2024; (24(1)):766 doi:10.1186/s12887-024-05245-5.
PMID: 39587513
This page provides educational information about the genetics of craniosynostosis-dysmorphism-brachydactyly syndrome. It does not replace professional medical advice; always consult a genetic counselor or physician regarding your family's specific genetic testing and planning.
Get notified when new evidence is published on Craniosynostosis-dysmorphism-brachydactyly syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.